E. Corsmit

发表

TheTNFRSF6 gene is not implicated in familial early-onset Alzheimer's disease

L. Feuk, A. Brookes, C. V. van Duijn, 2001, Human Genetics.

Mean age‐of‐onset of familial alzheimer disease caused by presenilin mutations correlates with both increased Aβ42 and decreased Aβ40

C. van Broeckhoven, M. Cruts, J. Theuns, 2006, Human mutation.

P3-395 Mean age-of-onset of familial Alzheimer disease caused by presenilin mutations correlates with both increased Aβ42 and decreased Aβ40

C. Broeckhoven, M. Cruts, J. Theuns, 2006, Alzheimer's & Dementia.

Linkage and association studies identify a novel locus for Alzheimer disease at 7q36 in a Dutch population-based sample.

K. Sleegers, C. van Broeckhoven, C. V. van Duijn, 2005, American journal of human genetics.

Genetic variability in the mitochondrial serine protease HTRA2 contributes to risk for Parkinson disease

C. van Broeckhoven, S. Engelborghs, P. D. De Deyn, 2008, Human mutation.

High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy.

G. Schellenberg, S. Melquist, D. Dickson, 2005, Human molecular genetics.

Relative contribution of simple mutations vs. copy number variations in five Parkinson disease genes in the Belgian population

C. van Broeckhoven, S. Engelborghs, P. D. De Deyn, 2009, Human mutation.

DLB and PDD: a role for mutations in dementia and Parkinson disease genes?

P. Deyn, C. Broeckhoven, S. Engelborghs, 2012, Neurobiology of Aging.

Comprehensive genetic and mutation analysis of familial dementia with Lewy bodies linked to 2q35-q36.

C. van Broeckhoven, S. Engelborghs, P. D. De Deyn, 2010, Journal of Alzheimer's disease : JAD.

Progranulin variability has no major role in Parkinson disease genetic etiology

C. Broeckhoven, K. Sleegers, S. Engelborghs, 2008, Neurology.

Genetic variant in the HSPB1 promoter region impairs the HSP27 stress response

C. van Broeckhoven, W. Robberecht, J. Theuns, 2007, Human mutation.

A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study

S. Pereson, C. Broeckhoven, K. Sleegers, 2012, The Lancet Neurology.

In vitro analysis of Alzheimer's disease-related presenilin 1 and 2 mutations: effect on beta-amyloid processing

C. Duijn, C. Broeckhoven, M. Cruts, 2002 .

Pilot Testing of the “Turbidimeter”, a Simple, Universal Reader Intended to Complement and Enhance Bacterial Growth Detection in Manual Blood Culture Systems in Low-Resource Settings

J. Jacobs, K. Kaur, L. Hardy, 2022, Diagnostics.

Promoter mutations that increase amyloid precursor-protein expression are associated with Alzheimer disease.

K. Sleegers, C. van Broeckhoven, S. Engelborghs, 2006, American journal of human genetics.

A Pan-European Study of the C9orf72 Repeat Associated with FTLD: Geographic Prevalence, Genomic Instability, and Intermediate Repeats

F. Jessen, G. Frisoni, K. Sleegers, 2012, Human mutation.

Alzheimer-associated C allele of the promoter polymorphism -22C>T causes a critical neuron-specific decrease of presenilin 1 expression.

C. van Broeckhoven, M. Cruts, J. Theuns, 2003, Human molecular genetics.

Alzheimer dementia caused by a novel mutation located in the APP C‐terminal intracytosolic fragment

B. Strooper, B. de Strooper, C. Broeckhoven, 2006, Human mutation.

Contribution of VPS35 genetic variability to LBD in the Flanders-Belgian population

P. Deyn, C. Broeckhoven, S. Engelborghs, 2012, Neurobiology of Aging.

The gene encoding nicastrin, a major gamma-secretase component, modifies risk for familial early-onset Alzheimer disease in a Dutch population-based sample.

P. S. St George-Hyslop, K. Sleegers, C. van Broeckhoven, 2002, American journal of human genetics.

Genetic risk and transcriptional variability of amyloid precursor protein in Alzheimer's disease.

K. Sleegers, C. van Broeckhoven, S. Engelborghs, 2006, Brain : a journal of neurology.

Progranulin locus deletion in frontotemporal dementia

C. Broeckhoven, S. Engelborghs, M. Cruts, 2008, Human mutation.

Global investigation and meta-analysis of the C9orf72 (G4C2)n repeat in Parkinson disease

D. Maraganore, A. Deutschländer, A. Lang, 2014, Neurology.

Genetic variability in the regulatory region of presenilin 1 associated with risk for Alzheimer's disease and variable expression.

C. Duijn, C. Broeckhoven, C. V. van Duijn, 2000, Human molecular genetics.

Guanosine triphosphate cyclohydrolase 1 promoter deletion causes dopa‐responsive dystonia

K. Sleegers, C. van Broeckhoven, S. Engelborghs, 2012, Movement disorders : official journal of the Movement Disorder Society.

GIGYF2 has no major role in Parkinson genetic etiology in a Belgian population

P. Deyn, C. Broeckhoven, S. Engelborghs, 2011, Neurobiology of Aging.

GIGYF2 has no major role in Parkinson genetic etiology in a Belgian population

P. Deyn, C. Broeckhoven, S. Engelborghs, 2011, Neurobiology of Aging.